Literature DB >> 26493848

Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma.

F Avilés-Jiménez1, A Guitron2, F Segura-López3, A Méndez-Tenorio4, S Iwai5, A Hernández-Guerrero6, J Torres7.   

Abstract

Biliary tract cancer or extrahepatic cholangiocarcinoma (ECCA) represents the sixth commonest cause of cancer in the gastrointestinal tract in western countries. We aimed to characterize the microbiota and its predicted associated functions in the biliary tract of ECCA and benign biliary pathology (BBP). Samples were taken from 100 patients with ECCA and 100 patients with BBP by endoscopic cholangio-pancreatography for DNA extraction. Ten patients with ECCA and ten with BBP were selected for microbiota studies using the V4-16S rRNA gene and sequenced in Illumina platform. Microbiota analyses included sample-to-sample distance metrics, ordination/clustering and prediction of functions. Presence of Nesterenkonia sp. and Helicobacter pylori cagA and vacA genes were tested in the 100 ECCA and 100 BBP samples. Phylum Proteobacteria dominated all samples (60.4% average). Ordination multicomponent analyses showed significant microbiota separation between ECCA and BBP (p 0.010). Analyses of 4002 operational taxonomic units with presence variation in at least one category probed a separation of ECCA from BBP. Among these, Nesterenkonia decreased, whereas Methylophilaceae, Fusobacterium, Prevotella, Actinomyces, Novosphingobium and H. pylori increased in ECCA. Predicted associated functions showed increased abundance of H. pylori virulence genes in ECCA. cagA and vacA genes were confirmed by PCR in ECCA and BBP samples. This is the first microbiota report in ECCA and BBP to show significant changes in microbial composition. Bacterial species unusual for human flora were found: Methylophilaceae and Nesterenkonia are reported in hypersaline soils, and Mesorhizobium is a nitrogen-fixing bacterium. Enrichment of virulence genes confirms previous studies suggesting that H. pylori might be associated with ECCA.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benign stenosis; Helicobacter pylori; Nesterenkonia; Novosphingobium; cholangiocarcinoma; microbiota

Mesh:

Substances:

Year:  2015        PMID: 26493848     DOI: 10.1016/j.cmi.2015.10.008

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  27 in total

1.  Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma.

Authors:  Elisa Herraez; Marta R Romero; Rocio I R Macias; Maria J Monte; Jose J G Marin
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

Review 2.  Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?

Authors:  Banchob Sripa; Raksawan Deenonpoe; Paul J Brindley
Journal:  Parasitol Int       Date:  2016-12-03       Impact factor: 2.230

3.  Characteristics of bile microbiota in cholelithiasis, perihilar cholangiocarcinoma, distal cholangiocarcinoma, and pancreatic cancer.

Authors:  Zhengqi Li; Jiangtao Chu; Feixiong Su; Xuan Ding; Yueming Zhang; Lizhou Dou; Yong Liu; Yan Ke; Xudong Liu; Yumeng Liu; Guiqi Wang; Linheng Wang; Shun He
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 4.  Intratumor microbiome in cancer progression: current developments, challenges and future trends.

Authors:  Jinyan Liu; Yi Zhang
Journal:  Biomark Res       Date:  2022-05-31

Review 5.  Gut microbiome in gastrointestinal cancer: a friend or foe?

Authors:  Yang Liu; Yoshifumi Baba; Takatsugu Ishimoto; Xi Gu; Jun Zhang; Daichi Nomoto; Kazuo Okadome; Hideo Baba; Peng Qiu
Journal:  Int J Biol Sci       Date:  2022-06-21       Impact factor: 10.750

Review 6.  Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.

Authors:  Roseanna C Wheatley; Elaine Kilgour; Timothy Jacobs; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  Br J Cancer       Date:  2021-10-18       Impact factor: 9.075

7.  Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.

Authors:  Rungtiwa Dangtakot; Kitti Intuyod; Anucha Ahooja; Jitraporn Wongwiwatchai; Petcharakorn Hanpanich; Aroonlug Lulitanond; Yaovalux Chamgramol; Somchai Pinlaor; Porntip Pinlaor
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

8.  The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies.

Authors:  Inge Huybrechts; Semi Zouiouich; Astrid Loobuyck; Zeger Vandenbulcke; Emily Vogtmann; Silvia Pisanu; Isabel Iguacel; Augustin Scalbert; Iciar Indave; Vitaly Smelov; Marc J Gunter; Nathalie Michels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-07-29       Impact factor: 4.254

9.  Liver Flukes and the Microbiota in Cancer.

Authors:  Lisa C Osborne; Laura WegenerParfrey
Journal:  EBioMedicine       Date:  2016-05-31       Impact factor: 8.143

10.  Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma.

Authors:  Kern Rei Chng; Sock Hoai Chan; Amanda Hui Qi Ng; Chenhao Li; Apinya Jusakul; Denis Bertrand; Andreas Wilm; Su Pin Choo; Damien Meng Yew Tan; Kiat Hon Lim; Roy Soetinko; Choon Kiat Ong; Dan G Duda; Simona Dima; Irinel Popescu; Chaisiri Wongkham; Zhu Feng; Khay Guan Yeoh; Bin Tean Teh; Puangrat Yongvanit; Sopit Wongkham; Vajaraphongsa Bhudhisawasdi; Narong Khuntikeo; Patrick Tan; Chawalit Pairojkul; Joanne Ngeow; Niranjan Nagarajan
Journal:  EBioMedicine       Date:  2016-05-06       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.